Letters Section Editor: Robert M. Golub, MD, Senior Editor.
In Reply: Drs Tondo and Baldessarini comment on our point that suicidal behavior in conditions such as bipolar disorder and schizophrenia may respond specifically to lithium and clozapine, respectively, by raising the interesting question as to why randomized controlled trials have not shown that antidepressants reduce rates of suicidal behavior in major depressive disorder. Part of the reason may be that clinical trials in major depression have almost uniformly not been designed to detect effects on suicidal behavior, and that most trials excluded acutely suicidal patients. Studies specifically designed to address this question are needed because use of antidepressants in major depression has emerged as the centerpiece of most suicide prevention efforts.
Mann JJ. Strategies to Prevent Suicide—Reply. JAMA. 2006;295(13):1515–1516. doi:10.1001/jama.295.13.1516-a
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.